Combination of biomarkers to predict mortality in elderly patients with myocardial infarction

Mechanisms of Ageing and Development

Volumn 129, Issue 4, 2008, Pages 231-237

  Olivieri, Fabiola ^a,b   Spazzafumo, Liana ^a   Antonicelli, Roberto ^a   Marchegiani, Francesca ^a   Cardelli, Maurizio ^a   Sirolla, Cristina ^a   Galeazzi, Roberta ^a   Giovagnetti, Simona ^a   Mocchegiani, Eugenio ^a   Franceschi, Claudio ^a,c  

^a Center of Genetic and Molecular Biology   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute myocardial infarction; CRP; Decision tree analysis; Elderly cardiovascular patients; Homocysteine

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ACUTE HEART INFARCTION; AGED; ARTICLE; CONTROLLED STUDY; DECISION TREE; FEMALE; FOLLOW UP; GENETIC MARKER; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MYOCARDIAL INFARCTION; SURVIVAL RATE;

EID: 39949085938     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2008.01.002     Document Type: Article

References (48)

1. Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563 (2005) 23-60
2. Antonicelli R., Olivieri F., Cavallone L., Spazzafumo L., Bonafe M., Marchegiani F., Cardelli M., Galeazzi R., Giovagnetti S., Perna G.P., and Franceschi C. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron. Artery Dis. 16 (2005) 489-493
3. Antonicelli R., Olivieri F., Bonafè M., Cavallone L., Spazzafumo L., Marchegiani F., Cardelli M., Recanatini A., Testarmata P., Galeazzi L., Boemi M., Parati G., and Franceschi C. The interleukin-6 -174 G>C promoter polymorphism is associated with an higher risk of death after an acute coronary syndrome in male elderly patients. Int. J. Cardiol. 103 (2005) 266-271
4. Austin P.C. A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality. Stat. Med. 26 (2007) 2937-2957
5. Bathum L., von Bornemann Hjelmborg J., Christiansen L., McGue M., Jeune B., and Christensen K. Methylenetetrahydrofolate reductase 677C>T and methionine synthase 2756A>G mutations: no impact on survival, cognitive functioning, or cognitive decline in nonagenarians. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007) 196-201
6. Beckman J.A., Preis O., Ridker P.M., and Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am. J. Cardiol. 96 (2005) 1374-1378
7. Bertrand M.E., Simoons M.L., Fox K.A., Wallentin L.C., Hamm C.W., McFadden E., De Feyter P.J., Specchia G., and Ruzyllo W. Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 23 (2002) 1809-1840
8. Bonaa K.H., Njolstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J.E., Arnesen E., and Rasmussen K. NORVIT Trial Investigators, 2006. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354 (2006) 1578-1588
9. Concato J., Feinstein A.R., and Holford T.R. The risk of determining risk with multivariable models. Ann. Intern. Med. 118 3 (1993) 201-210
10. Cummings D.M., King D.E., Mainous A.G., and Geesey M.E. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 180-185
11. Dickens C., McGowan L., Percival C., Tomenson B., Cotter L., Heagerty A., and Creed F. Depression is a risk factor for mortality after myocardial infarction: fact or artifact?. J. Am. Coll. Cardiol. 49 (2007) 1834-1840
12. European Society of Hypertension-European Society of Cardiology Guidelines and Committee, European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 21, 1011-1053.
13. Fletcher G.F., Mills W.C., and Taylor W.C. Update on exercise stress testing. Am. Fam. Phys. 74 (2006) 1749-1754
14. Foussas S.G., Zairis M.N., Lyras A.G., Patsourakos N.G., Tsirimpis V.G., Katsaros K., Beldekos D.J., Handanis S.M., Mytas D.Z., Karidis K.S., Tselioti P.G., Prekates A.A., and Ambrose J.A. Early prognostic usefulness of C-reactive protein added to the Thrombolysis in Myocardial Infarction risk score in acute coronary syndromes. Am. J. Cardiol. 96 (2005) 533-537
15. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., and De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 908 (2000) 244-254
16. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., and Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007) 92-105
17. Giacconi R., Cipriano C., Albanese F., Boccoli G., Saba V., Olivieri F., Franceschi C., and Mocchegiani E. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp. Gerontol. 39 (2004) 621-628
18. Giacconi R., Cipriano C., Muti E., Costarelli L., Malavolta M., Caruso C., Lio D., and Mocchegiani E. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology 7 (2006) 347-356
19. Girelli D., Martinelli N., Olivieri O., Pizzolo F., Friso S., Faccini G., Bozzini C., Tenuti I., Lotto V., Villa G., Guarini P., Trabetti E., Pignatti P.F., Mazzucco A., and Corrocher R. Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS ONE 20 1 (2006) e83
20. Gori A.M., Corsi A.M., Fedi S., Gazzini A., Sofi F., Bartali B., Bandinelli S., Gensini G.F., Abbate R., and Ferrucci L. A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am. J. Clin. Nutr. 82 (2005) 335-341
21. Gruenewald T.L., Seeman T.E., Ryff C.D., Karlamangla A.S., and Singer B.H. Combinations of biomarkers predictive of later life mortality. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 14158-14163
22. Hultdin J., Thogersen A.M., Jansson J.H., Nilsson T.K., Weinehall L., and Hallmans G. Elevated plasma homocysteine: cause or consequence of myocardial infarction?. J. Intern. Med. 256 (2004) 491-498
23. Kammersgaard L.P., and Olsen T.S. Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study. Cerebrovasc. Dis. 21 (2006) 187-193
24. Kass G.V. An exploratory technique for investigating large quantities of categorical data. Appl. Stat. 29 (1980) 119-127
25. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., and Schouten E.G. MTHFR Studies Collaboration Group. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (2002) 2023-2031
26. Lange L.A., Carlson C.S., Hindorff L.A., Lange E.M., Walston J., Durda J.P., Cushman M., Bis J.C., Zeng D., Lin D., Kuller L.H., Nickerson D.A., Psaty B.M., Tracy R.P., and Reiner A.P. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 (2006) 2703-2711
27. Laupacis A., Labelle R., Goeree R., and Cairns J. The cost-effectiveness of routine post myocardial infarction exercise stress testing. Can. J. Cardiol. 6 (1990) 157-163
28. Lee K.W., Hill J.S., Walley K.R., and Frohlich J.J. Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. CMAJ 174 (2006) 461-466
29. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., McQueen M.J., Probstfield, Fodor G., Held C., and Genest Jr. J. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354 (2006) 1567-1577
30. Lowe G.D.O. The association between elevated levels of inflammation biomarkers and coronary artery disease and death. CMAJ 174 (2006) 479-480
31. Lowe G.D.O. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J. Thromb. Haemost. 3 (2005) 1618-1627
32. McDade T.W., Hawkley L.C., and Cacioppo J.T. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom. Med. 68 (2006) 376-381
33. Malavolta M., Mocchegiani E., and Bertoni-Freddari C. New trends in biomedical aging research. Gerontology 50 (2004) 420-424
34. Mager A., Koren-Morag N., Shohat M., Harell D., and Battler. Family history, plasma homocysteine, and age at onset of symptoms of myocardial ischemia in patients with different methylenetetrahydrofolate reductase genotypes. Am. J. Cardiol. 95 (2005) 1420-1424
35. Palazzuoli A., Deckers J., Calabro A., Campagna M.S., Nuti R., Pastorelli M., Pasqui A.L., Bruni F., Auteri A., and Puccetti L. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. Am. J. Cardiol. 98 (2006) 1322-1328
36. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., and Vinicor F. Centers for Disease Control and Prevention; American Heart Association. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-551
37. Pearte C.A., Furberg C.D., O'Meara E.S., Psaty B.M., Kuller L., Powe N.R., and Manolio T. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation 113 (2006) 2177-2185
38. Ranjit N., Diez-Roux A.V., Shea S., Cushman M., Seeman T., Jackson S.A., and Ni H. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch. Intern. Med. 167 (2007) 174-181
39. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997. Diabetes Care 20, 1183-1197.
40. Roest M., van der Schouw Y.T., Grobbee D.E., Tempelman M.J., de Groot P.G., Sixma J.J., and Banga J.D. Methylenetetrahydrofolate reductase 677 C/T genotype and cardiovascular disease mortality in postmenopausal women. Am. J. Epidemiol. 153 (2001) 673-679
41. Rossi G.P., Maiolino G., Seccia T.M., Burlina A., Zavattiero S., Cesari M., Sticchi D., Pedon L., Zanchetta M., and Pessina A.C. Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J. Hypertens. 24 (2006) 851-859
42. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., and Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J. Am. Coll. Cardiol. 45 (2005) 637-651
43. Schmaltz H.N., Southern D., Ghali W.A., Jelinski S.E., Parsons G.A., King K.M., and Maxwell C.J. Living alone, patient sex and mortality after acute myocardial infarction. J. Gen. Intern. Med. 22 (2007) 572-578
44. Stork S., Feelders R.A., van den Beld A.W., Steyerberg E.W., Savelkoul H.F., Lamberts S.W., Grobbee D.E., and Bots M.L. Prediction of mortality risk in the elderly. Am. J. Med. 119 (2006) 519-525
45. Sun J., Xu Y., Xue J., Zhu Y., and Lu H. Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients. Mol. Cell. Endocrinol. 229 (2005) 95-101
46. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., and Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb. Haemost. 95 (2006) 511-518
47. Weikert C., Hoffmann K., Dierkes J., Zyriax B.C., Klipstein-Grobusch K., Schulze M.B., Jung R., Windler E., and Boeing H. A homocysteine metabolism-related dietary pattern and the risk of coronary heart disease in two independent German study populations. J. Nutr. 135 (2005) 1981-1988
48. Zee R.Y., Mora S., Cheng S., Erlich H.A., Lindpaintner K., Rifai N., Buring J.E., and Ridker P.M. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin. Chem. 53 (2007) 845-851